IGHE and Eczematoid dermatitis: Oral L. rhamnosus CGMCC supplementation to pregnant mice was shown to prevent the development of atopic dermatitis (eczema) when the newborns were also treated for the first 12 weeks, with reduced clinical symptoms, total plasma IgE levels and enhanced IFN-γ in skin biopsies (Curran, 2011).